How to Treat Dermatofibroma: Surgical & Non-Surgical Options

Most dermatofibromas never need treatment at all. These firm, button-like skin bumps are benign, and the vast majority remain stable over time without causing harm. When a dermatofibroma does bother you, whether because it itches, catches on clothing, or simply looks unappealing, the options run from complete surgical removal to less invasive approaches like cryotherapy, laser treatment, and steroid injections. Each method involves a different trade-off between how thoroughly it eliminates the lesion and what kind of scar or recurrence risk it leaves behind.

When Treatment Is Actually Worth Considering

Dermatofibromas carry an excellent prognosis. They do not spread, and spontaneous regression has even been documented in some cases. Most remain the same size for years or decades, and many people live with them indefinitely without any problems. Treatment is generally reserved for lesions that are symptomatic (tender, itchy, or painful when bumped) or cosmetically bothersome in a visible location like the lower leg, arm, or face.¹

If your dermatofibroma is small, painless, and tucked away somewhere you rarely notice it, a dermatologist will often recommend doing nothing. That is not a dismissal; it is a legitimate clinical decision based on the fact that every treatment option carries some risk of scarring or recurrence, and the original bump poses essentially zero health risk. The conversation changes when the lesion is growing quickly, is larger than about a centimeter, or when there is any concern it might not actually be a dermatofibroma. Those situations warrant a biopsy and sometimes more aggressive removal.

Surgical Excision

Complete surgical excision is the most definitive treatment. A dermatologist or surgeon cuts out the entire lesion, usually with a margin of normal-looking skin around it, and closes the wound with stitches. The main advantage is that it removes the dermatofibroma entirely and provides tissue for pathological examination, so you get a confirmed diagnosis at the same time. Excision produces the lowest recurrence rate of any approach.¹

The trade-off is the scar. Because dermatofibromas extend into the deeper layers of the skin, the excision has to go fairly deep to get clean margins. On the lower legs, where dermatofibromas commonly appear, wounds tend to heal more slowly and scars can be more noticeable. Many patients find themselves weighing whether the scar from surgery would actually look worse than the original bump. For a small, flat dermatofibroma on the shin, the answer is sometimes yes, and a dermatologist might steer you toward a less invasive option or observation.

Shave Removal

Shave excision is a middle ground: the protruding part of the lesion is shaved flush with (or slightly below) the skin surface using a blade, but the deeper tissue is left in place. This is quicker, heals with a flatter scar, and does not require deep sutures. The downside is that the root of the dermatofibroma remains, so recurrence rates are higher than with full excision. Some patients find this acceptable since the bump was their main complaint, not the underlying tissue they could not see or feel.

Cryotherapy

Liquid nitrogen cryotherapy freezes the lesion, causing the treated tissue to blister and eventually peel away. A study of 35 dermatofibromas treated with cryotherapy reported good or excellent results in over 90% of cases. Adding aspirin and a topical steroid to the treatment appeared to reduce side effects like prolonged redness and swelling.²

Cryotherapy works best for lesions that are relatively flat and where the main complaint is the bump’s appearance rather than deep tenderness. It does not remove the lesion entirely, so recurrence is possible. The treated area often heals with a lighter patch of skin (hypopigmentation), which can be more visible on darker skin tones. This makes cryotherapy a less popular choice for patients concerned about skin-color changes at the treatment site.

Laser Treatments

Laser therapy has become an increasingly studied option for dermatofibromas, with two main laser types showing promise. The approach does not remove the lesion outright but can substantially flatten it and fade its color, sometimes to the point where it is no longer noticeable.

Pulsed Dye Laser

The pulsed dye laser (PDL) targets blood vessels in the skin, which helps reduce redness and can shrink the lesion. In one study using a 600 nm PDL, three-quarters of the treated dermatofibromas showed a complete response in volume and size, and 60% had complete resolution of their color. All six lesions that were tender or irritating before treatment became completely symptom-free afterward.³ A separate study confirmed that PDL produced clinical improvement of more than 50% in the majority of treated lesions, with about 73% of patients rating themselves satisfied or very satisfied with the outcome.⁴

Multiple sessions are typically required, spaced several weeks apart. The cosmetic results can be better than surgical excision because laser treatment does not leave a traditional scar. For patients whose primary concern is how their dermatofibroma looks rather than how it feels, this is often a strong option.

Combining Laser Types

Some dermatologists use a combination approach, pairing a PDL with a Q-switched alexandrite laser. The PDL targets the vascular component (redness, blood vessel dilation), while the alexandrite laser targets brown pigmentation. A study using a 595 nm PDL alongside a 755 nm Q-switched alexandrite laser found that 14 of the treated patients experienced complete disappearance of brown color, and 15 felt a noticeable decrease in the lesion’s hardness. Patient satisfaction was described as very high.⁵

The combination approach addresses both the color and texture of a dermatofibroma, which a single laser type sometimes cannot fully manage on its own. Most patients in these studies required a series of sessions, but the results suggest that this dual-laser strategy is worth discussing with your dermatologist if the lesion has both a prominent bump and dark discoloration.

Intralesional Steroid Injections

Injecting a corticosteroid directly into the dermatofibroma can shrink it and relieve symptoms like itching. Triamcinolone acetonide at a concentration of 10 mg/mL is the agent typically used. Case reports describe clinical improvement starting within about a week, with the lesion becoming smaller and itching resolving. After several weeks of treatment, the bump can flatten significantly, though a residual dark spot may remain.⁶

This method is particularly useful for patients who want symptom relief without surgery or visible scarring. The evidence base is smaller than for excision or lasers, consisting mostly of case reports rather than large trials, so it is worth setting expectations with your doctor beforehand. Repeated injections carry a small risk of local skin thinning or depigmentation at the injection site, a side effect common to all intralesional steroid use.

How to Choose Between Options

The “best” treatment depends on what bothers you about the lesion and how much risk of recurrence or scarring you are willing to accept. A few practical considerations:

If it hurts or itches: Steroid injections can resolve symptoms quickly without leaving a scar. PDL also eliminated tenderness in every symptomatic lesion treated in the study discussed above.
If it sticks out: Shave removal flattens the bump immediately. Cryotherapy and lasers can also reduce prominence but require multiple visits.
If the color bothers you: Laser therapy (especially the PDL plus alexandrite combination) addresses pigmentation more effectively than any surgical method, which may leave a scar that is itself discolored.
If you want it gone for good: Full surgical excision offers the lowest recurrence rate. Everything else leaves some deeper tissue behind and carries a higher chance the bump returns.
If you want the least scarring: Lasers and steroid injections produce the least visible scarring. Cryotherapy can leave a pale spot. Surgery leaves a linear scar.

Location matters too. Dermatofibromas on the lower legs heal slowly after excision, and the scars can spread. Lesions on the trunk or upper arms tend to produce better surgical scars. A dermatologist can help weigh the specifics based on your skin type, the size of the lesion, and where it sits on your body.

Cellular Dermatofibromas and Recurrence

Not all dermatofibromas behave the same way. The “cellular” variant is a subtype that grows more aggressively and has a reputation for recurring after removal. Older literature reported recurrence rates as high as 26% to 50% for cellular dermatofibromas, which made them sound far more worrisome than typical lesions. A more recent review of 218 cases suggests the reality is less dire: when the excision margins were involved (meaning some tumor cells remained at the edge of the removed tissue), the recurrence rate was about 10%. Lesions larger than 1 cm at the time of removal appeared more likely to come back.⁷

If you are told you have a cellular dermatofibroma, the standard recommendation is complete excision with clear margins rather than a partial approach like shave removal or cryotherapy. The difference in recurrence risk justifies the more involved procedure. Your pathologist can confirm whether margins are clear after the tissue is examined under a microscope, and if they are not, re-excision is usually recommended.

Multiple Eruptive Dermatofibromas and Immune Connections

Developing many dermatofibromas at once, a pattern called multiple eruptive dermatofibromas, is uncommon and sometimes signals something going on with the immune system. Case reports and reviews have linked this pattern to autoimmune diseases and immunosuppressive therapy. One case series noted the association with conditions like Takayasu’s arteritis, suggesting that chronic inflammatory states can influence the behavior of the skin cells that form dermatofibromas.⁸

If you are suddenly developing clusters of firm bumps rather than a single lesion, it is worth mentioning to your doctor even if you suspect they are dermatofibromas. The bumps themselves are managed the same way as solitary dermatofibromas, but the eruption pattern may prompt your doctor to screen for underlying conditions. In people on immunosuppressive drugs, adjusting the medication sometimes slows the appearance of new lesions, though this decision always has to be balanced against the reason the medication was prescribed in the first place.

When It Might Not Be a Dermatofibroma at All

The main reason dermatologists take dermatofibromas seriously, even though they are benign, is that they can occasionally be confused with a much rarer tumor called dermatofibrosarcoma protuberans (DFSP). DFSP is a low-grade sarcoma that invades locally and requires wide surgical excision. Clinically, the two can look similar: both present as firm, skin-colored to brownish bumps, and both commonly appear on the trunk or limbs.

Several features help tell them apart under the microscope. Standard immunohistochemical staining shows that most DFSPs are positive for the marker CD34 (about 96% in one study) while most dermatofibromas are negative for it. Conversely, dermatofibromas are usually positive for factor XIIIa (about 94%) and stromelysin-3 (about 91%), while DFSPs typically lack both.⁹ A newer marker called Cthrc1 adds further discrimination: 96% of DFSPs stained positive for it versus just 9% of dermatofibromas in the same study. Nuclear morphology under the microscope is also distinctive, with one analysis finding that a specific alternating cell shape pattern was present in 98% of DFSPs but absent in all dermatofibromas examined.¹⁰

None of this is something you would evaluate yourself, but it is useful to know the red flags that should prompt a biopsy rather than watchful waiting. A dermatofibroma that grows rapidly, exceeds a couple of centimeters in diameter, or is accompanied by swollen lymph nodes warrants a closer look.¹ If your doctor has already biopsied the lesion and confirmed it as a typical dermatofibroma, you can proceed with whichever treatment approach suits your situation without worrying about a missed diagnosis.

What Dermoscopy Reveals

If you have ever had a dermatologist examine your bump with a handheld magnifying device pressed against your skin, they were using a dermatoscope. Under dermoscopy, dermatofibromas have a fairly characteristic look: a central whitish patch surrounded by a delicate brown network of pigment at the periphery. That pigment network is produced by hyperpigmentation of cells at the base of the outermost skin layer, not by melanocyte activity the way a mole’s color is produced.¹¹

However, the dermoscopic appearance is more variable than textbooks suggest. A prospective study catalogued 17 distinct dermoscopic patterns across a range of dermatofibroma subtypes. The classic central white patch with peripheral pigment network accounted for only about 21% of cases. Atrophic dermatofibromas tended to show patchy networks with white patches, while aneurysmal and hemosiderotic variants displayed more prominent blood vessel patterns.¹² This variability is part of why experienced dermatologists sometimes biopsy a lesion even when it “probably” looks like a dermatofibroma: the non-classic patterns overlap with those of other tumors, and certainty matters when deciding on treatment.

Interestingly, dermoscopy is also useful for tracking treatment response. Studies using laser therapy noted that the pigment network visible before treatment disappeared entirely after the laser sessions, providing an objective way to confirm that the treatment was working beyond just how the lesion looked to the naked eye.⁵

1
PubMed Central. Dermatofibroma: Reappraisal and Updated Review
2
Clinical and Experimental Dermatology. Cryotherapy for dermatofibromas
3
PubMed. Treatment of dermatofibroma with a 600 nm pulsed dye laser
4
PubMed. Dermatofibromas treated with pulsed dye laser: Clinical and dermoscopic outcomes
5
PubMed. Prospective Study of Q Switched Alexandrite Laser 755 nm and V Beam Pulsed Dye Laser 595 nm in Dermatofibroma
6
Media Dermato-Venereologica Indonesiana. DERMATOFIBROMA YANG DITERAPI DENGAN INJEKSI TRIAMSINOLON ASETONID INTRALESI
7
PubMed. Cellular Dermatofibroma: Clinicopathologic Review of 218 Cases of Cellular Dermatofibroma to Determine the Clinical Recurrence Rate
8
PubMed Central. Multiple Eruptive Dermatofibromas: A Case Series and Review of Diagnostic Challenges and Systemic Associations
9
PubMed. Collagen triple helix repeat containing-1 in the differential diagnosis of dermatofibrosarcoma protuberans and dermatofibroma
10
PubMed Central. Dermatofibroma vs. Dermatofibrosarcoma Protuberans: A Nuclear Morphology Study
11
PubMed Central. Multiple Dermatofibromas: Dermoscopic Patterns
12
PubMed Central. Beyond classic dermoscopic patterns of dermatofibromas: a prospective research study